Sign in

CIK 0001652130 · Large accelerated filer

Intellia Therapeutics, Inc.

Sign in to watch
Ticker
NTLA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364785571
Phone
857-285-6200
Business address
400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market sale EVP, General Counsel sold 5,615 shares at $21.00 ($117,915)
  4. 4 Open-market sale President and CEO sold 5,000 shares at $21.83 ($109,150)
  5. 8-K Event Material agreement · Other events
  6. 424B5 Offering Prospectus
  7. 424B5 Offering Prospectus
  8. 8-K Event Material agreement · Unregistered share sale · Other events
  9. 4 Open-market sale EVP, General Counsel sold 5,615 shares at $21.21 ($119,094)
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. DEFA14A Proxy Proxy Materials
  15. DEF 14A Proxy Proxy Statement
  16. 8-K Event Bylaws or fiscal year change
  17. SC 13D/A Stake Beneficial Ownership Report
  18. 8-K Event Other events
  19. 8-K Event Material agreement · New debt or obligation
  20. 4 Derivatives Options or other derivatives

Page 23 of 37 · 725 filings